Peer-reviewedCC BY-NC-NDCurrent urology
Comment on: The interconnection between androgen receptor and DNA damage response pathways in prostate cancer.
- 1Urology and Kidney Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
- 2Urology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Related
- Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer
- ERG inhibition selectively sensitizes ERG-positive prostate cancer to radiation through DNA repair vulnerabilities and enhances response to androgen receptor inhibitors.
- TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism
- Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependence
- Interdependent androgen and glucocorticoid receptor signalling shapes prostate epithelial homeostasis
BibTeX
@article{lasorsa2026comment,
title = {{Comment on: The interconnection between androgen receptor and DNA damage response pathways in prostate cancer.}},
author = {Francesco Lasorsa and Giuseppe Lucarelli},
journal = {Current urology},
year = {2026},
month = jul,
doi = {10.1097/cu9.0000000000000361},
url = {https://europepmc.org/article/MED/43012011},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Comment on: The interconnection between androgen receptor and DNA damage response pathways in prostate cancer.
AU - Francesco Lasorsa
AU - Giuseppe Lucarelli
PY - 2026
DA - 2026/07/10
JO - Current urology
DO - 10.1097/cu9.0000000000000361
UR - https://europepmc.org/article/MED/43012011
SN - 1661-7649
SN - 1661-7657
ER -